Coherus BioSciences is adding to its pipeline, this time grabbing commercialization rights for a biosimilar of one of the largest ophthalmology drugs on the market.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,